Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Perceptions of cancer prevention options for Lynch syndrome (LS) in a multi-national convenience sample.
Authors
Michael J. Hall
Fox Chase Cancer Center, Philadelphia, PA
Michael J. Hall , Sachi Singhal , Nadine Osorio , Juan Pablo Chavez , Emma D. Riggs , Yana Chertock , Mary Beryl Daly
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 77)
DOI
10.1200/JCO.2024.42.3_suppl.77
Abstract #
77
Poster Bd #
E20
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Attitudes toward prevention options in Lynch syndrome (LS): Comparing frameshift peptide vaccination (FSPVAX), colonoscopy (COLO), and aspirin (ASA) chemoprevention.
First Author: Michael J. Hall
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prevalence and predictors of aspirin/NSAID use among patients with Lynch syndrome (LS).
First Author: Sachi Singhal
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Outcomes with immunotherapy between Lynch syndrome vs non-Lynch syndrome microsatellite instability-high colorectal cancer.
First Author: Cody Eslinger
Poster
2023 ASCO Annual Meeting
A comprehensive analysis of clinical characterization in 149 Chinese patients with Lynch syndrome.
First Author: Junqiong Lin